Literature DB >> 9245682

Distributions of smokers by stage: international comparison and association with smoking prevalence.

J F Etter1, T V Perneger, A Ronchi.   

Abstract

OBJECTIVES: The goals of this study were to describe the distribution of smokers by stage of change in Geneva, Switzerland; to compare this result with distributions observed in other countries; and to assess whether, across samples from different countries, the stage distribution of current smokers was associated with the prevalence of smoking.
METHODS: Two mailed surveys were conducted in Geneva in 1995-1996, in a representative sample of residents (n = 742) and in a representative sample of university members (n = 2,270). A literature review produced seven studies describing the stage distribution in representative samples.
RESULTS: In the Geneva population, 74% of smokers were in the precontemplation stage, 22% in contemplation, and 4% in preparation. In the university sample, the corresponding figures were 72, 20, and 8%. Our results were similar to other European samples, but less favorable than in American samples, where these distributions were typically 40, 40, and 20%, respectively. Across all samples, a low prevalence of smoking was associated with a more favorable stage distribution (r = 0.88, P = 0.002).
CONCLUSIONS: Interventions in Europe need to take into account the large proportion of precontemplators repeatedly observed among smokers. A shift to the right of the distribution of current smokers across stages may help increase quit rates and thereby reduce smoking prevalence. This hypothesis should be tested in prospective intervention studies.

Mesh:

Year:  1997        PMID: 9245682     DOI: 10.1006/pmed.1997.0179

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  44 in total

Review 1.  Four beliefs that may impede progress in the treatment of smoking.

Authors:  J R Hughes
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Short-term impact of a university based smoke free campaign.

Authors:  J F Etter; A Ronchi; T Perneger
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

Review 3.  Motivating and helping smokers to stop smoking.

Authors:  John R Hughes
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

4.  Predictors of long-term outcome of a smoking cessation programme in primary care.

Authors:  Gonzalo Grandes; Josep M Cortada; Arantza Arrazola; Jon P Laka
Journal:  Br J Gen Pract       Date:  2003-02       Impact factor: 5.386

5.  Integrating population smoking cessation policies and programs.

Authors:  James O Prochaska; Wayne F Velicer
Journal:  Public Health Rep       Date:  2004 May-Jun       Impact factor: 2.792

6.  Comparing an immediate cessation versus reduction approach to smokeless tobacco cessation.

Authors:  Katherine R Schiller; Xianghua Luo; Amanda J Anderson; Joni A Jensen; Sharon S Allen; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2012-01-04       Impact factor: 4.244

Review 7.  New methods for tobacco dependence treatment research.

Authors:  Timothy B Baker; Robin Mermelstein; Linda M Collins; Megan E Piper; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Michael C Fiore
Journal:  Ann Behav Med       Date:  2011-04

8.  Individual and family factors associated with intention to quit among male Vietnamese American smokers: implications for intervention development.

Authors:  Janice Y Tsoh; Elisa K Tong; Ginny Gildengorin; Tung T Nguyen; Mary V Modayil; Ching Wong; Stephen J McPhee
Journal:  Addict Behav       Date:  2010-11-27       Impact factor: 3.913

9.  Prevalence and correlates of tobacco use among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia.

Authors:  Robert A Schnoll; Paul F Engstrom; Somasundaram Subramanian; Lev Demidov; Dustin B Wielt; Mourad Tighiouart
Journal:  Int J Behav Med       Date:  2006

Review 10.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.